Role of peptide growth factors in the prostate: a review.

Suppr

超能文献

作者信息

Steiner M S

机构信息

Department of Urology, Vanderbilt University School of Medicine, Nashville, Tennessee.

出版信息

Urology. 1993 Jul;42(1):99-110. doi: 10.1016/0090-4295(93)90352-b.

DOI:10.1016/0090-4295(93)90352-b

PMID:7687082

Abstract

摘要

相似文献

Role of peptide growth factors in the prostate: a review.

Urology. 1993 Jul;42(1):99-110. doi: 10.1016/0090-4295(93)90352-b.

The role of growth factors in the pathogenesis of BPH.生长因子在良性前列腺增生发病机制中的作用。

Prog Clin Biol Res. 1994;386:43-50.

Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy.良性前列腺增生症和泌尿系统恶性肿瘤中肽生长因子的综述。

J Urol. 1995 Apr;153(4):1085-96.

Regulation of prostatic growth and function by peptide growth factors.肽生长因子对前列腺生长和功能的调节

Prostate. 1996 Jun;28(6):392-405. doi: 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C.

Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.雄激素和肽生长因子对人良性前列腺增生中前列腺生长的双重调控

Mol Cell Endocrinol. 1991 Jun;78(1-2):C77-81. doi: 10.1016/0303-7207(91)90174-q.

[Role of growth factors in the etiopathogenesis of benign prostatic hyperplasia].[生长因子在良性前列腺增生症发病机制中的作用]

Actas Urol Esp. 1994 May;18 Suppl:359-64.

[Peptide growth factors in the prostate].[前列腺中的肽生长因子]

Pathol Biol (Paris). 1993 Oct;41(8):731-40.

Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.转化生长因子α和β、表皮生长因子、角质形成细胞生长因子及其受体在胎儿和成人前列腺组织及癌细胞系中的差异基因表达。

Urology. 1996 Dec;48(6):963-70. doi: 10.1016/s0090-4295(96)00376-7.

Nonandrogenic mediators of prostatic growth.

Hematol Oncol Clin North Am. 2001 Jun;15(3):459-76. doi: 10.1016/s0889-8588(05)70226-4.

Potential role of HBGF (FGF) and TGF-beta on prostate growth.

Adv Exp Med Biol. 1992;324:107-14. doi: 10.1007/978-1-4615-3398-6_11.

引用本文的文献

Design and Synthesis of Analogues of Marine Natural Product Galaxamide, an N-methylated Cyclic Pentapeptide, as Potential Anti-Tumor Agent in Vitro.海洋天然产物加拉酰胺（一种N-甲基化环五肽）类似物的设计与合成，作为潜在的体外抗肿瘤剂

Mar Drugs. 2016 Sep 3;14(9):161. doi: 10.3390/md14090161.

Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.纤维母细胞生长因子受体基因在韩国良性前列腺增生中的作用。

Dis Markers. 2013;35(6):869-75. doi: 10.1155/2013/792941. Epub 2013 Dec 9.

Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?将前驱糖尿病与良性前列腺增生联系起来。IGFBP-3：良性前列腺增生发展管弦乐队的指挥？

PLoS One. 2013 Dec 19;8(12):e81411. doi: 10.1371/journal.pone.0081411. eCollection 2013.

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.局部晚期前列腺癌中血管内皮生长因子（VEGF）的表达：放射肿瘤学组（RTOG）8610 的二次分析。

Radiat Oncol. 2013 Apr 25;8:100. doi: 10.1186/1748-717X-8-100.

Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.神经肽诱导的蛋白酶体活性上调先于核因子 κB 在雄激素非依赖性前列腺癌细胞中的激活。

Cancer Cell Int. 2012 Jun 20;12(1):31. doi: 10.1186/1475-2867-12-31.

Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.地塞米松和睾酮处理对去势后大鼠前列腺腹侧胰岛素降解酶和细胞变化的调节作用。

Int J Exp Pathol. 2011 Aug;92(4):272-80. doi: 10.1111/j.1365-2613.2011.00772.x. Epub 2011 Apr 21.

Stat3 promotes metastatic progression of prostate cancer.信号转导与转录激活因子3（Stat3）促进前列腺癌的转移进程。

Am J Pathol. 2008 Jun;172(6):1717-28. doi: 10.2353/ajpath.2008.071054. Epub 2008 May 15.

Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.抗雌激素药物和选择性雌激素受体调节剂可降低前列腺癌风险。

World J Urol. 2003 May;21(1):31-6. doi: 10.1007/s00345-002-0316-x. Epub 2003 Feb 14.

Immunopathological prognostic and predictive factors in prostate cancer.前列腺癌中的免疫病理预后和预测因素。

Int Urol Nephrol. 2002;34(1):63-71. doi: 10.1023/a:1021306928664.

Hormonal treatment of patients with benign prostatic hyperplasia: pros and cons.良性前列腺增生患者的激素治疗：利弊

Curr Urol Rep. 2001 Aug;2(4):285-91. doi: 10.1007/s11934-001-0065-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验